desacetylcefotaxime has been researched along with Pneumococcal-Infections* in 1 studies
1 trial(s) available for desacetylcefotaxime and Pneumococcal-Infections
| Article | Year |
|---|---|
Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.
We determined cefotaxime and desacetyl-cefotaxime concentrations in children with bacterial meningitis receiving high-dose cefotaxime (300 mg/kg of body weight/day) and concomitant dexamethasone therapy. The median peak cerebrospinal fluid cefotaxime and desacetyl-cefotaxime concentrations were 4.7 and 8.1 microg/ml, respectively. In vitro bactericidal activity (>99.9% killing in 6 h) was found in 17 (94%), 13 (72%), and 8 (44%) of 18 cerebrospinal fluid specimens against cefotaxime-susceptible, -intermediate (MIC, 1 microg/ml), and -resistant (MIC, 4 microg/ml) strains, respectively. High-dose cefotaxime, while safe, is not reliably sufficient therapy for cephalosporin-nonsusceptible pneumococcal meningitis, and combination therapy is recommended. Topics: Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child; Dose-Response Relationship, Drug; Humans; Meningitis; Pneumococcal Infections; Serum Bactericidal Test; Streptococcus pneumoniae | 1997 |